Michela Zuccolo
L'Oréal
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michela Zuccolo.
Journal of Investigative Dermatology | 2014
Florian Meisgen; Ning Xu Landén; Aoxue Wang; Bence Rethi; Charbel Bouez; Michela Zuccolo; Audrey Gueniche; Mona Ståhle; Enikö Sonkoly; Lionel Breton; Andor Pivarcsi
Keratinocytes represent the first line of defense against pathogens in the skin and have important roles in initiating and regulating inflammation during infection and autoimmunity. Here we investigated the role of miR-146a in the regulation of the innate immune response of keratinocytes. Toll-like receptor 2 (TLR2) stimulation of primary human keratinocytes resulted in an NF-κB- and mitogen-activated protein kinase-dependent upregulation of miR-146a expression, which was surprisingly long lasting, contrasting with the rapid and transient induction of inflammatory mediators. Overexpression of miR-146a significantly suppressed the production of IL-8, CCL20, and tumor necrosis factor-α, which functionally suppressed the chemotactic attraction of neutrophils by keratinocytes. Inhibition of endogenous miR-146a induced the production of inflammatory mediators even in nonstimulated keratinocytes, and potentiated the effect of TLR2 stimulation. Transcriptomic profiling revealed that miR-146a suppresses the expression of a large number of immune-related genes in keratinocytes. MiR-146a downregulated interleukin-1 receptor-associated kinase 1 and TNF receptor-associated factor 6, two key adapter molecules downstream of TLR signaling, and suppressed NF-κB promoter-binding activity as shown by promoter luciferase experiments. Together, these data identify miR-146a as a regulatory element in keratinocyte innate immunity, which prevents the production of inflammatory mediators under homeostatic conditions and serves as a potent negative feedback regulator after TLR2 stimulation.
Journal of Biological Chemistry | 2012
Mariangela Pucci; Nicoletta Pasquariello; Natalia Battista; Monia Di Tommaso; Cinzia Rapino; Filomena Fezza; Michela Zuccolo; Roland Jourdain; Alessandro Finazzi Agrò; Lionel Breton; Mauro Maccarrone
Background: Endocannabinoids like anandamide (AEA) play a key role in skin biology. Results: At high concentrations, AEA induces apoptosis of primary human melanocytes through TRPV1 receptors, whereas at low concentrations, it stimulates melanogenesis through CB1 receptors. Conclusion: AEA regulates cell death or melanin synthesis through different pathways. Significance: The double effect of AEA on human melanocytes might have implications beyond skin biology. We show that a fully functional endocannabinoid system is present in primary human melanocytes (normal human epidermal melanocyte cells), including anandamide (AEA), 2-arachidonoylglycerol, the respective target receptors (CB1, CB2, and TRPV1), and their metabolic enzymes. We also show that at higher concentrations AEA induces normal human epidermal melanocyte apoptosis (∼3-fold over controls at 5 μm) through a TRPV1-mediated pathway that increases DNA fragmentation and p53 expression. However, at lower concentrations, AEA and other CB1-binding endocannabinoids dose-dependently stimulate melanin synthesis and enhance tyrosinase gene expression and activity (∼3- and ∼2-fold over controls at 1 μm). This CB1-dependent activity was fully abolished by the selective CB1 antagonist SR141716 or by RNA interference of the receptor. CB1 signaling engaged p38 and p42/44 mitogen-activated protein kinases, which in turn activated the cyclic AMP response element-binding protein and the microphthalmia-associated transcription factor. Silencing of tyrosinase or microphthalmia-associated transcription factor further demonstrated the involvement of these proteins in AEA-induced melanogenesis. In addition, CB1 activation did not engage the key regulator of skin pigmentation, cyclic AMP, showing a major difference compared with the regulation of melanogenesis by α-melanocyte-stimulating hormone through melanocortin 1 receptor.
Experimental Dermatology | 2014
Florian Meisgen; Ning Xu Landén; Charbel Bouez; Michela Zuccolo; Audrey Gueniche; Mona Ståhle; Enikö Sonkoly; Lionel Breton; Andor Pivarcsi
Keratinocytes recognize invading pathogens by various receptors, among them Toll‐like receptors (TLRs), and provide the first line of defense in skin immunity. The role of microRNAs in this important defense mechanism has not been explored yet. Our aim was to identify microRNAs involved in the innate immune response of keratinocytes. MicroRNA expression profiling revealed that the TLR2 ligand zymosan, the TLR3 ligand poly(I:C) or the TLR5 ligand flagellin significantly altered the microRNA expression in keratinocytes. The regulation of microRNAs was concentration‐dependent and it could be neutralized by siRNAs specific for TLR2, TLR3 and TLR5, respectively, confirming the specificity of the TLR response. Interestingly, one microRNA, miR‐146a, was strongly induced by all studied TLR ligands, while other microRNAs were regulated in a TLR‐ or time point‐specific manner. These findings suggest an important role for microRNAs in the innate immune response of keratinocytes and provide a basis for further investigations.
Archive | 2013
Lionel Breton; Audrey Gueniche; Michela Zuccolo; Annick Mercenier; Guénolé Prioult
Archive | 2017
Annick Mercenier; Audrey Gueniche; Guénolé Prioult; Lionel Breton; Michela Zuccolo
Archive | 2017
Annick Mercenier; Audrey Gueniche; Guénolé Prioult; Lionel Breton; Michela Zuccolo
Archive | 2014
Roland Jourdain; Michela Zuccolo; Lionel Breton; Mauro Maccarrone
Archive | 2013
Lionel Breton; Michela Zuccolo; Audrey Gueniche
Archive | 2013
Michela Zuccolo; Lionel Breton
Archive | 2012
Lionel Breton; Michela Zuccolo; Audrey Gueniche